DA Davidson Maintains Buy on Beauty Health, Lowers Price Target to $16.5
Portfolio Pulse from jenniferd'souza@benzinga.com
DA Davidson analyst Linda Bolton Weiser maintains a 'Buy' rating on Beauty Health (NASDAQ:SKIN) but lowers the price target from $35 to $16.5.
August 10, 2023 | 2:13 pm
News sentiment analysis
Sort by:
Descending
NEUTRAL IMPACT
DA Davidson maintains a 'Buy' rating on Beauty Health but lowers the price target from $35 to $16.5.
The news is directly related to Beauty Health (NASDAQ:SKIN). While the 'Buy' rating is maintained, the lowering of the price target from $35 to $16.5 could potentially create uncertainty among investors, possibly leading to short-term volatility in the stock price. However, the overall impact is neutral as the 'Buy' rating is still in place.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100